Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tom D. Spies is active.

Publication


Featured researches published by Tom D. Spies.


Annals of Internal Medicine | 1939

RECENT ADVANCES IN THE TREATMENT OF PELLAGRA AND ASSOCIATED DEFICIENCIES

Tom D. Spies; William B. Bean; William F. Ashe

Excerpt In 1735 Gaspar Casal, a Spanish physician, first described pellagra and shrewdly pointed out that this disease is related to an inadequate diet.1That diet was the controlling factor in the ...


Annals of Internal Medicine | 1947

THE USE OF FOLIC ACID IN SPRUE

Ramón M. Suárez; Tom D. Spies

Excerpt A number of investigators have already shown that Addisonian pernicious anemia, non-tropical sprue, and related macrocytic anemias are promptly relieved by the administration of synthetic f...


Journal of Dental Research | 1947

The Influence of Sodium Bisulphite on Acid Production in Saliva

Samuel Dreizen; Arvin W. Mann; Tom D. Spies; Bess C. Carson; J.K. Cline

The rdle of acids in tooth decalcification (1) is now generally accepted. As a result recent attempts at dental caries control have been in the direction of decreasing the rate of acid formation in the mouth, and/or increasing the rate of acid neutralization in regions associated with the caries susceptible portions of the teeth (2). Since the latter has been considered difficult to achieve, methods and means of decreasing the rate of acid formation in the mouth have been the aim of most of the recent investigations in this field. Controlled diet, oral hygiene, and interference with the enzyme or coenzyme systems necessary for carbohydrate degradation have each presented distinct possibilities. Chemical inhibitors of enzyme systems has been studied by Stephan (3) using urea, Zander (4) using ammoniacal silver nitrate, Dean, Jay, Arnold, and Elvove (5) using the fluoride ion, and most recently Burrill, Calandra, Tilden, and Fosdick (6) using synthetic vitamin K. These investigators have all succeeded in reducing significantly the rate of acid formation in the saliva. The work of Burrill, Calandra, Tilden, and Fosdick (6) was particularly interesting because a 2-methyl 1,4-napthoquinone-sodium bisulphite addition compound was employed. The results were attributed to the quinone which was regarded by these investigators as the active ingredient, the sodium bisulphite being used for the purpose of rendering the 2-methyl 1,4-napthoquinone water soluble so it would be more rapidly absorbed (7). Sodium bisulphite, however, has had some use in medicine as an antiseptic and an antifermentation agent (8). The possible effect of sodium bisulphite on the results obtained by Burrill, Calandra, Tilden, and Fosdick stimulated investigation in regard to the action of this salt on the process of acid production in saliva. Since Burrill and his associates used less than 0.75 mg. sodium bisulphite in their study with 2-methyl 1,4-napthoquinone (6), a series of preliminary tests were made using varying concentrations of sodium bisulphite. It was found that values ranging from 2.5 mg. to 10 mg. showed a definite interference with the acid formation, the most efficient concentration ranging from


Annals of Internal Medicine | 1940

Adenylic acid in human nutrition.

Tom D. Spies; William B. Bean; Richard W. Vilter

Excerpt From our studies of a large series of persons with mixed vitamin deficiency, we reported recently1, 2, 3that the diagnostic manifestations of pellagra, beriberi, riboflavin deficiency, vita...


Annals of Internal Medicine | 1939

THE EFFECT OF ROENTGEN-RAY ON THE BLOOD CODEHYDROGENASES I AND II

William B. Bean; Richard W. Vilter; Tom D. Spies

Excerpt It is a well known fact that therapeutic doses of roentgen-ray frequently give rise to a train of symptoms characterized by nausea, vomiting, abdominal cramps, headache and general malaise....


JAMA | 1938

THE USE OF NICOTINIC ACID IN THE TREATMENT OF PELLAGRA

Tom D. Spies; Clark Cooper; Marion A. Blankenhorn


JAMA | 1938

The Treatment of Subclinical and Classic Pellagra. Use of Nicotinic Acid, Nicotinic Acid Amide and Sodium Nicotinate, with Special Reference to the Vasodilator Action and the Effect on Mental Symptoms.

Tom D. Spies; William B. Bean; Robert E. Stone


JAMA | 1939

Pellagra, Beriberi and Riboflavin Deficiency in Human Beings. Diagnosis and Treatment.

Tom D. Spies; Richard W. Vilter; William F. Ashe


The American Journal of the Medical Sciences | 1938

The Mental Symptoms of Pellagra. Their Relief with Nicotinic Acid.

Tom D. Spies; Charles D. Aring; Jules Gelperin; William B. Bean


JAMA | 1946

EFFECT OF FOLIC ACID ON PERSONS WITH MACROCYTIC ANEMIA IN RELAPSE

Tom D. Spies

Collaboration


Dive into the Tom D. Spies's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

William B. Bean

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arvin W. Mann

University of Cincinnati

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge